Data Sheet 1_From traditional metabolic markers to ensemble learning: comparative application of machine learning models for predicting NAFLD risk in adolescents.csv by Chenming Zhang (455452)

“…Background<p>Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent among adolescents and poses a significant public health challenge. …”

Characteristics of selected studies. by Tao Yang (184280)

Subgroup and sensitivity analyses. by Tao Yang (184280)

Methodology and reporting assessment. by Tao Yang (184280)

Data Sheet 1_Global, regional, and national burden of pulmonary arterial hypertension in adults aged ≥60 years from 1990–2021: SDI-stratified trend analysis and projections to 2050... by Guorui Xu (10273592)

“…</p>Results<p>Between 1990 and 2021, the number of new cases increased by 130%, deaths by 130%, and disability-adjusted life years (DALYs) increased by 100%. …”

Meta-analysis of included studies. by Tao Yang (184280)

Funnel plots of the included studies. by Tao Yang (184280)

Flow diagram of study selection process. by Tao Yang (184280)

Filamentation, invasion, and hyphal length of the <i>C. albicans</i> oak tree isolates and the sugar-adapted strain on intestinal epithelial cells. by Theresa Lange (22403918)

Data Sheet 10_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 1_Identification and trajectory of multimorbidity patterns among older people in China: a longitudinal study based on the China health and retirement longitudinal study... by Qian Liu (135614)

“…Background<p>Multimorbidity presents a significant global health challenge, particularly among older people in China; however, research on its patterns and dynamic evolution remains limited. …”

Data Sheet 2_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 9_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 6_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Table 1_Molecular identification and pathogenic impact of Pythium aphanidermatum on ginger (Zingiber officinale): insights into oxidative stress, antioxidant responses, and mycotox... by Mukesh Meena (5877473)

Data Sheet 1_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 3_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 7_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Data Sheet 8_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip by Shi-Long Wang (2229925)

“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”

Supplementary file 1_Effects of anti-osteoporotic drugs in patients with chronic kidney disease: a systemic review and network meta-analysis of bone mineral density, clinical fract... by Chih-Hsuan Wung (21555686)

“…Three AODs: sclerostin inhibitors, bisphosphonates and parathyroid hormone (PTH) analogs were associated with mild but significantly increased BMD at the lumbar spine, total hip, and femoral neck. …”